Intraocular Inflammation

The Bascom Palmer Angiogenesis meeting took place on Feb. 8, covering disease pathogenesis and emerging treatment options for various retinal conditions. The presentations highlighted how some of the newest imaging modalities are helping us understand the natural course of disease and new mechanisms of action being evaluated as alternatives to our current treatments. Below is just a mere highlight of many excellent presentations at the meeting.

This year’s American Academy of Ophthalmology meeting in San Francisco had significant data releases from pharmaceutical companies focused on the treatment of neovascular age-related macular degeneration with gene therapy.

SAN FRANCISCO — The phase 1b study of KSI-301, a novel anti-VEGF antibody polymer, improved best corrected visual acuity, and showed strong efficacy and safety for patients with either wet age-related macular degeneration, diabetic macular edema/diabetic retinopathy or retinal vein occlusion, according to a speaker here.